Wagner J S, Adson M A, Van Heerden J A, Adson M H, Ilstrup D M
Ann Surg. 1984 May;199(5):502-8. doi: 10.1097/00000658-198405000-00002.
Five-year survival after resection of hepatic metastases from colorectal cancer is 25%. Although resection palliates some patients who do not live that long, 50% of patients so treated are not helped at all. Until ignorance of a cancer's real stage is resolved by improved techniques, the evaluation and choice of therapy can be based only upon knowledge of the natural history of untreated metastases and determinants of prognosis derived from treated patients. Analysis of the survival rates of 252 patients who had biopsy proven, unresected hepatic metastases that were the only evidence of residual disease shows the extent to which natural history, rather than resection, may determine length of survival-- and indicates the need for critical analysis of 2- and 3-year survival rates reported after any therapy. Study of 141 patients who had hepatic metastases resected shows that the stage of the primary lesion, being female, and the absence of extrahepatic metastases are significant determinants of favorable prognosis after resection of hepatic metastases.
结直肠癌肝转移切除术后的五年生存率为25%。虽然手术切除可使部分生存期较短的患者病情得到缓解,但接受该治疗的患者中有50%根本没有从中获益。在通过改进技术解决对癌症真实分期的认知不足之前,治疗的评估和选择只能基于对未经治疗的转移瘤自然病程的了解以及来自接受治疗患者的预后决定因素。对252例经活检证实存在未切除肝转移且这是残余疾病唯一证据的患者的生存率分析表明,自然病程而非手术切除可能在很大程度上决定生存期,这也表明需要对任何治疗后报告的2年和3年生存率进行批判性分析。对141例接受肝转移切除术患者的研究表明,原发灶的分期、女性性别以及无肝外转移是肝转移切除术后预后良好的重要决定因素。